Abstract
Recurrence within the pelvis of ovarian cancer is a common mechanism of treatment failure [1]. This pattern of recurrence presents a poor prognosis and usually is a lethal clinical situation. In an attempt to curatively resect pelvic recurrence and to optimally treat advanced primary ovarian cancer, complete pelvic peritonectomy combined with intraperitoneal chemotherapy has been used. This cytoreductive approach to cancer treatment represents a new strategy for advanced pelvic malignancy. The complete pelvic peritonectomy is a surgical procedure in which all of the parietal and visceral peritoneal surfaces at risk for seeding of cancer are removed. The dissections included a stripping of the pelvic peritoneum, a low resection of the sigmoid colon, and an en bloc removal of all female genitalia.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Sugarbaker TA, Sugarbaker PH. Patterns of treatment failure for ovarian cancer. In Sugarbaker PH, ed. Peritoneal Carcinomatosis: Drugs and Diseases. Norwell, MA: Kluwer Academic, 1995, pp 63–73.
Sugarbaker PH. Cytoreductive approach to peritoneal carcinomatosis: Peritonectomy and intraperitoneal chemotherapy, Postgrad Adv Colorectal Surg 1991;II-X:1–13.
Sugarbaker PH. A perspective on clinical research strategies in carcinoma of the large bowel. World J Surg 1991;15:609–616.
Sugarbaker PH, Landy D, Jaffe G, Pascar R. Histologic changes induced by intraperitoneal chemotherapy with 5-fluorouracil an mitomycin C in patients with peritoneal carcinomatosis from cystadenocarcinoma of the colon or appendix. Cancer 1990;65:1495–1501.
Sugarbaker PH, Graves T, DeBruijn EA, Cunliffe WJ, Mullins RE, Hull WE, et al. Early postoperative intraperitoneal chemotherapy, and adjuvant therapy to surgery for peritoneal carcinomatosis from gastrointestinal cancer: Pharmacological studies. Cancer Res 1991;50:5790–5794.
Sugarbaker PH. Intraperitoneal Chemotherapy and Cytoreductive Surgery: Manual for Physicians and Nurses. Grand Rapids, MI: Ludann, 1993.
Steichen FM, Ravitch MM. Mechanical sutures in esophageal surgery. Surgery 1980;191:373–381.
Gorden PH, Vasilevsky CA. Experience with stapling in rectal surgery. Surg Clin North Am 1984;64:555–566.
Smith LE. Anastomosis with EEA stapler after anterior colonic resection. Dis Colon Rectum 1981;124:236–242.
Leff EI, Hoexter B, Labow SB, Eisenstat TE, Rubin RJ, Salvati EP. The EEA stapler in low colorectal anastomosis. Dis Colon Rectum 1982;25:704–707.
Burke EC, Welvaart K. Complications of stapled anastomosis in anterior resection for rectal carcinoma. J Surg Oncol 1990;45:180–183.
Wong J, Cheung H, Lui R, Fan YW, Smith A, Siu KF. Esophago-gastric anastomosis performed with a stapler. Surgery 1987;xx:480–415.
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1996 Kluwer Academic Publishers, Boston
About this chapter
Cite this chapter
Sugarbaker, P.H. (1996). Complete parietal and visceral peritonectomy of the pelvis for advanced primary and recurrent ovarian cancer. In: Sugarbaker, P.H. (eds) Peritoneal Carcinomatosis: Drugs and Diseases. Cancer Treatment and Research, vol 81. Springer, Boston, MA. https://doi.org/10.1007/978-1-4613-1245-1_8
Download citation
DOI: https://doi.org/10.1007/978-1-4613-1245-1_8
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-7923-3726-3
Online ISBN: 978-1-4613-1245-1
eBook Packages: Springer Book Archive